Delirium, Dementia, Amnestic, Cognitive Disorders  >>  donepezil transdermal patch (IPI-301)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
donepezil transdermal patch (IPI-301) / Icure Pharm
NCT01860625: A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects

Completed
1
36
RoW
Donepezil patch, placebo
Icure Pharmaceutical Inc.
Alzheimer Disease
12/13
02/14
NCT02178124: A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.

Completed
1
24
RoW
Donepezil, placebo
Icure Pharmaceutical Inc.
Alzheimer Disease
12/14
12/14

Download Options